On April 5, 2021, Amneal Pharmaceuticals, Inc. (NYSE:AMRX) completed its acquisition of Kashiv Specialty Pharmaceuticals, LLC (KSP). As a result, KSP is now operating as part of Amneal. Over the coming weeks, we expect to complete the work that will seamlessly integrate our two companies and strengthen our capabilities and value. In the meantime, we are focused on business continuity as well as our commitment to patients, vendors, partners and other key stakeholders.